Funds trio key shareholders in Open Orphan merger firm

A trio of London funds have emerged as major shareholders in Venn Life Sciences as part of its merger with Open Orphan.

The company announced last week that it has raised £4.5 million (€5 million) from investors to fund the reverse takeover of Dublin-based Open Orphan.

According to regulatory filings on Friday, Miton Asset Management and Crux Asset Management will each own 3.5 per cent of Open Orphan after the fundraising is complete. ...